Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    Springer Science and Business Media LLC ; 2020
    In:  Histochemistry and Cell Biology Vol. 154, No. 6 ( 2020-12), p. 655-662
    In: Histochemistry and Cell Biology, Springer Science and Business Media LLC, Vol. 154, No. 6 ( 2020-12), p. 655-662
    Abstract: Prostaglandin induced signalling is involved in different cancers. As previously described, the EP3 receptor expression decreases with increasing stage of cervical intraepithelial lesions (CIN). In addition, in cervical cancer EP3 is an independent prognosticator for overall survival and correlates with FIGO stages. Currently the role of Prostaglandin 2 receptor 2 (EP2) in CIN is unknown. The aim of this study was to analyse the expression of EP2 for potential prognostic value for patients with cervical dysplasia. EP2 expression was analysed by immunohistochemistry in 33 patient samples (CIN1–3) using the immune-reactivity scoring system (IRS). Expression levels were correlated with clinical outcome to analyse prognostic relevance in patients with CIN2. Data analysis was performed using non parametric Kruskal–Wallis and Spearman rank sum test. Cytoplasmic expression levels of EP2 correlated significantly ( p   〈  0.001) with different grades of cervical dysplasia. Median EP2-IRS in CIN1 was 2 ( n  = 8), 3 in CIN2 ( n  = 9) and 6 in CIN3 ( n  = 16). Comparing regressive ( n  = 3, median IRS = 2) to progressive ( n  = 6, median IRS = 4) CIN2 cases the median IRS differed significantly ( p  = 0.017). Staining intensity ( p  = 0.009) and IRS ( p  = 0.005) of EP2 and EP3 correlate inversely. EP2 expression level significantly increases with higher grade of CIN and could qualify as a potential prognostic marker for the regressive or progressive course in CIN2 lesions. These findings emphasize the significant role of PGE2 signalling in CIN and could help to identify targets for future therapies.
    Type of Medium: Online Resource
    ISSN: 0948-6143 , 1432-119X
    RVK:
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2020
    detail.hit.zdb_id: 1398345-3
    SSG: 12
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages